1. Home
  2. GRML vs TACT Comparison

GRML vs TACT Comparison

Compare GRML & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$0.44

Market Cap

41.9M

Sector

N/A

ML Signal

N/A

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$3.36

Market Cap

37.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRML
TACT
Founded
N/A
1996
Country
United States
United States
Employees
5
N/A
Industry
Computer peripheral equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
37.2M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
GRML
TACT
Price
$0.44
$3.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
3.6M
18.0K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.88
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.36
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$3.06
52 Week High
$0.50
$5.70

Technical Indicators

Market Signals
Indicator
GRML
TACT
Relative Strength Index (RSI) 55.80 50.51
Support Level $0.31 $3.22
Resistance Level N/A $3.45
Average True Range (ATR) 0.06 0.11
MACD 0.01 0.01
Stochastic Oscillator 66.98 63.04

Price Performance

Historical Comparison
GRML
TACT

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: